StockData

Drugs Made In America Acquisition II Corp. (DMII) stock

DMIINasdaqBlank ChecksFiscal year ends December 31Also trades as DMIIR, DMIIU
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 16, 2026
$10.23−0.01 (-0.15%)

Close on Nov 18, 2026Market cap $140.15MP/E –Yield –

Drugs Made In America Acquisition II enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Drugs Made In America Acquisition II's enterprise value was $140.56M on Nov 11, 2026.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$140.56M-8.7%
2025Dec 31, 2025$153.88M–

More Drugs Made In America Acquisition II figures

See a number that looks wrong?